Education
About Us
Working with TipRanks
Follow Us
Veradigm Inc. (MDRX)
:MDRX
MDRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.00 - $11.80
Previous CloseN/A
Volume6.73K
Average Volume (3M)201.79K
Market Cap
$710.53M
Enterprise ValueN/A
Total Cash (Recent Filing)$174.20M
Total Debt (Recent Filing)$669.40M
Price to Earnings (P/E)―
Beta0.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding169,578,480
10 Day Avg. Volume268,816
30 Day Avg. Volume201,787
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.32
Price to Cash Flow (P/CF)4.30
P/FCF Ratio5.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$11.00Price Target Upside158.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Veradigm News
PremiumCompany Announcements
Veradigm Appoints New Directors to Strengthen Governance
PremiumCompany Announcements
Veradigm Files Annual Report with Restated Financials
PremiumCompany Announcements
Veradigm Faces Delays in Annual Report FilingPremiumCompany Announcements
Veradigm Expands Board with Strategic Appointments
---
Ownership Overview
0.83% Insiders
1.77% Mutual Funds
2.08% Other Institutional Investors
95.32% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MDRX FAQ
What was Veradigm Inc.’s price range in the past 12 months?
Veradigm Inc. lowest stock price was $4.00 and its highest was $11.80 in the past 12 months.
What is Veradigm Inc.’s market cap?
Veradigm Inc.’s market cap is $710.53M.
When is Veradigm Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Veradigm Inc.’s earnings last quarter?
Veradigm Inc. released its earnings results on Nov 02, 2023. The company reported $0.215 earnings per share for the quarter, the consensus estimate of $0.215 by $0.
Is Veradigm Inc. overvalued?
According to Wall Street analysts Veradigm Inc.’s price is currently Undervalued.
Does Veradigm Inc. pay dividends?
Veradigm Inc. does not currently pay dividends.
What is Veradigm Inc.’s EPS estimate?
Veradigm Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Veradigm Inc. have?
Veradigm Inc. has 169,578,480 shares outstanding.
What happened to Veradigm Inc.’s price movement after its last earnings report?
Veradigm Inc. reported an EPS of $0.215 in its last earnings report, expectations of $0.215. Following the earnings report the stock price went up 1.329%.
Which hedge fund is a major shareholder of Veradigm Inc.?
Currently, no hedge funds are holding shares in MDRX
---
Veradigm Stock Smart Score
Company Description
Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
---
MDRX Stock 12 Month Forecast
Average Price Target
$11.00
▲(158.22% Upside)
Technical Analysis
Best Analysts Covering MDRX
1 Year
1 Year Success Rate
2/14 ratings generated profit
1 Year Average Return
-19.77%
reiterated a buy rating 9 days ago
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -19.77% per trade.
---